RAIA DROGASIL S.A. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 24.9 BRL | -1.27% |
|
-5.61% | -15.31% |
| Mar. 06 | Transcript : Raia Drogasil S.A., Q4 2023 Earnings Call, Mar 06, 2024 | |
| Mar. 05 | Raia Drogasil S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Sales 2024 * | 39.21B 7.48B | Sales 2025 * | 44.75B 8.53B | Capitalization | 42.69B 8.14B |
|---|---|---|---|---|---|
| Net income 2024 * | 1.39B 265M | Net income 2025 * | 1.8B 344M | EV / Sales 2024 * | 1.27 x |
| Net Debt 2024 * | 7.03B 1.34B | Net Debt 2025 * | 7.51B 1.43B | EV / Sales 2025 * | 1.12 x |
| P/E ratio 2024 * |
30.1
x | P/E ratio 2025 * |
22.3
x | Employees | 57,700 |
| Yield 2024 * |
1.12% | Yield 2025 * |
1.94% | Free-Float | 74.06% |
More Fundamentals
* Assessed data
More news
Latest transcript on Raia Drogasil S.A.
More press releases
| 1 day | -1.27% | ||
| 1 week | -5.61% | ||
| Current month | -9.02% | ||
| 1 month | -7.78% | ||
| 3 months | -9.45% | ||
| 6 months | -9.98% | ||
| Current year | -15.31% |
1 week
24.70
26.75
1 month
24.7028.41
Current year
24.3029.87
1 year
24.1130.15
3 years
17.1430.15
5 years
12.2230.15
10 years
3.4330.15
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 61 | 13-06-30 | |
| Director of Finance/CFO | 60 | 13-04-28 | |
| Investor Relations Contact | 53 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 63 | 11-11-23 | |
| Director/Board Member | 72 | 13-04-28 | |
| Director/Board Member | 70 | 11-11-23 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 2.01% | 21 M€ | -14.00% | - | |
| 1.35% | 12 M€ | +15.09% | - | |
| 1.21% | 15 M€ | -4.90% | ||
| 1.19% | 32 M€ | -8.82% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-17 | 24.9 | -1.27% | 8,470,000 |
| 24-04-16 | 25.22 | -3.74% | 7,146,800 |
| 24-04-15 | 26.2 | -0.61% | 6,160,600 |
| 24-04-12 | 26.36 | +0.04% | 6,571,000 |
| 24-04-11 | 26.35 | -0.11% | 4,327,800 |
Delayed Quote Sao Paulo, April 17, 2024 at 04:07 pm EDT
More quotes
Raia Drogasil S.A. specializes in the distribution of medicines, cosmetics and dermocosmetics, perfumery, personal care and beauty products. Net sales break down by family of products as follows:
- branded pharmaceuticals (42%);
- pharmaceutical additives (25.1%) ;
- OTC products (21.3%);
- generic pharmaceutical products (11.4%).
At the end of 2020, its products were marketed through a network of 2,299 pharmacies under the Drogasil (1,304) and Raia (995) brands in Brazil.
Sector
Drug Retailers
Calendar
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
24.9
BRL
Average target price
30.93
BRL
Spread / Average Target
+24.22%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -15.31% | 8.16B | |
| +31.40% | 1.31B | |
| +4.71% | 417M | |
| +10.36% | 295M | |
| +14.44% | 231M | |
| -4.59% | 88.08M | |
| -44.18% | 86.07M | |
| +18.61% | 58.61M |
- Stock Market
- Equities
- RADL3 Stock
